MarketPeel
Insider Trading Intelligence
JG

Jonathan Gillis

MPLT
CAAO AND PAO · MAPLIGHT THERAPEUTICS, INC. · CIK 0001709954
FILING MIX · LIFETIME22%/78%
BUYS
4
SELLS
14
TOTAL VALUE
$3.95M
COMPANIES
1
ACTIVE SINCE
Oct 2025
HOLDINGS NOW
144,240
AVG SELL PX
$29.84
TRADE KIND
SHOWING 18 / 18
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
6 backtested trades · 8 horizons · 18 pendingHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by Jonathan Gillis, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d6+83.33%-2.70%+1.03%-3.73%-7.02%
14d6+83.33%+1.19%+3.21%-2.01%-4.46%
30d6+83.33%-1.38%+6.05%+2.83%+2.83%
60d6+50.00%+1.04%+3.14%-2.11%-4.49%
90d6+0.00%+24.23%+4.11%+20.12%+16.40%
180d6(6 pending)
1y6(6 pending)
2y6(6 pending)
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
MPLT · 144,240 shares · as of Jul 17, 2026
063,631127,262190,892254,5232026SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2025
2026
2026
2026
FLOW · 4 buys / 14 sellsCOVERAGE · 4 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
MPLT
MAPLIGHT THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
900$38.17$34.4K144,240Jul 17, 2026Jul 20, 2026View →
MPLT
MAPLIGHT THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
16,969$37.61$638.2K145,140Jul 17, 2026Jul 20, 2026View →
MPLT
MAPLIGHT THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
600$36.51$21.9K162,109Jul 17, 2026Jul 20, 2026View →
MPLT
MAPLIGHT THERAPEUTICS, INC.
SALE
CAO and Interim CFO
1,476$37.44$55.3K162,709Jul 16, 2026Jul 20, 2026View →
MPLT
MAPLIGHT THERAPEUTICS, INC.
SALE
CAO and Interim CFO
6,979$36.66$255.9K164,185Jul 16, 2026Jul 20, 2026View →
MPLT
MAPLIGHT THERAPEUTICS, INC.
SALE
CAO and Interim CFO
5,356$36.13$193.5K175,863Jul 15, 2026Jul 20, 2026View →
MPLT
MAPLIGHT THERAPEUTICS, INC.
SALE
CAO and Interim CFO
4,699$36.94$173.6K171,164Jul 15, 2026Jul 20, 2026View →
MPLT
MAPLIGHT THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
17,235$30.33$522.7K181,919Apr 28, 2026Apr 29, 2026View →
MPLT
MAPLIGHT THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
700$30.83$21.6K181,219Apr 28, 2026Apr 29, 2026View →
MPLT
MAPLIGHT THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
29,623$29.60$876.8K213,517Apr 27, 2026Apr 29, 2026View →
MPLT
MAPLIGHT THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
14,363$30.46$437.5K199,154Apr 27, 2026Apr 29, 2026View →
MPLT
MAPLIGHT THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
7,914$28.94$229.0K243,140Apr 27, 2026Apr 29, 2026View →
MPLT
MAPLIGHT THERAPEUTICS, INC.
SALE
CAAO and PAO
3,590$26.61$95.5K251,054Apr 15, 2026Apr 17, 2026View →
MPLT
MAPLIGHT THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
6,020254,523Feb 5, 2026Feb 9, 2026View →
MPLT
MAPLIGHT THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
24,45524,455Feb 5, 2026Feb 9, 2026View →
MPLT
MAPLIGHT THERAPEUTICS, INC.
SALE
CAAO and PAO
22,050$17.98$396.5K248,503Jan 27, 2026Jan 29, 2026View →
MPLT
MAPLIGHT THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
124,022124,022Oct 27, 2025Oct 28, 2025View →
MPLT
MAPLIGHT THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
30,56530,565Oct 27, 2025Oct 28, 2025View →
Other insiders · MPLT
Loading peer insiders…
About this filer
CIK 0001709954
ROLE
CAAO and PAO
PRIMARY
MPLT
COMPANIES
1
ACTIVE SINCE
Oct 2025
MARKETPEEL · /INSIDER/0001709954DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback